Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Aerpio raises $40M ahead of planned OTC listing

Aerpio Pharmaceuticals Inc. (Cincinnati, Ohio) raised $40 million in a private placement and completed a

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE